Physician profile
Richard Callihan
NPI 1154386241
$3,090.70
in general payments reported to CMS, 2019-2025
16 companies · $35.98 in 2025
The $35.98 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $160 · 2021: $306 · 2022: $588 · 2023: $1,072 · 2024: $452 · 2025: $35.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,696.59 | 2019-2024 | Synergy, Avvigo Guidance System, Watchman Flx |
| Medtronic, INC. | $394.99 | 2022-2023 | Onyx Frontier |
| Heartflow, INC. | $198.47 | 2023 | Ffrct |
| Abbott Laboratories | $156.61 | 2023 | Mitraclip, Diamondback Coronary |
| Abiomed | $153.73 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $109.81 | 2019-2022 | |
| Cardiovascular Systems INC. | $96.92 | 2022-2023 | Diamondback Coronary |
| Cathworks, INC. | $96.18 | 2023 | Ffrangio |
| Novartis Pharmaceuticals Corporation | $34.92 | 2019-2025 | |
| Edwards Lifesciences Corporation | $27.27 | 2022 | |
| Siemens Medical Solutions USA, INC. | $25.92 | 2019 | |
| Inari Medical, INC. | $25.37 | 2022 | |
| Pfizer INC. | $24.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.87 | 2025 | Jardiance |
| Amgen INC. | $15.69 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Callihan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.